Mark Bullock has been appointed as Independent Chair of Cambridge Cancer Research Hospital’s Building and Construction Board (BCB).
Mark retired as CEO of Balfour Beatty construction in December 2023, a role he had held since 2020. Prior to that he headed up the Rail and Utilities businesses having joined Balfour Beatty in 2012. He led these multi-billion pound businesses at a pivotal time for the construction industry, following the Covid-19 pandemic.
Mark has held a range of leadership roles over the past 30 years including at Heathrow airport, EDF energy, Hays PLC, and Laing O’Rourke, who were appointed as Cambridge Cancer Research Hospital’s preferred construction partner last summer.
The Building and Construction Board is a decision-making body that will oversee the design, construction and fit-out of Cambridge Cancer Research Hospital.
The Cambridge Cancer Research Hospital programme is a partnership between Cambridge University Hospitals, the University of Cambridge and its Cancer Research UK Cambridge Centre (CRUK CC), that will support the ambitions set out in the government’s Life Sciences Vision, and the NHS Long Term Plan.
The Chair of the BCB will therefore act on behalf of both partners, and in an independent capacity, to ensure the Cancer Hospital programme is delivered to time and budget.
Mark brings a huge amount of experience to the role, having recently overseen the construction of the 86,000m2 Midland Metropolitan University Hospital, which sits in Cohort 1 of the Government’s New Hospital Programme. While Cambridge Cancer Research Hospital sits within Cohort 2, it remains on track to be the first hospital delivered in the East of England as part of the programme.
Welcoming his appointment, Claire Stoneham, Director of Strategy and Major Projects at Cambridge University Hospitals said:
“We are delighted to have Mark Bullock as our Independent Chair, advising on construction of our new hospital, and bringing an impressive amount of current construction industry experience.
“His appointment is a significant step in ensuring we have the capability, knowledge and expertise to deliver this specialist cancer research hospital, that will make a huge difference to many patients across the region, and the UK.”
Pre-construction works are set to begin this summer for Cambridge Cancer Research Hospital, with full construction works starting on the future site next to AstraZeneca, Royal Papworth Hospital and Addenbrooke's Hospital, in 2025.